Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Armitage

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of the Royal College of Surgeons of England|January 25, 2002
Laparoscopic pyeloplasty, initial experience in the management of UPJOV J Gnanapragasam, T G Armitage
Progress in Clinical and Biological Research|January 1, 1990
Tumour markers in monitoring the treatment of advanced prostate cancerE H Cooper, T G Armitage
Postgraduate Medical Journal|December 1, 1987
Immediate versus deferred treatment for early prostatic cancerP H Smith, T G Armitage
Postgraduate Medical Journal|January 1, 1983
Primary peritonitis in children and adultsT G Armitage, R C Williamson
Progress in Clinical and Biological Research|January 1, 1990
The biochemical monitoring of prostate cancer. Yorkshire Regional Urological Cancer Research GroupE H Cooper, T G Armitage
Progress in Clinical and Biological Research|January 1, 1990
Deferred treatment in localized prostatic cancerP H Smith, T G Armitage, E H Cooper
British Journal of Urology|December 1, 1988
The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancerT G Armitage, E H Cooper, D W Newling, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
Cancer|September 1, 1990
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancerE H Cooper, T G Armitage, M R Robinson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of the Royal College of Surgeons of England|January 25, 2002
Laparoscopic pyeloplasty, initial experience in the management of UPJOV J Gnanapragasam, T G Armitage
Progress in Clinical and Biological Research|January 1, 1990
Tumour markers in monitoring the treatment of advanced prostate cancerE H Cooper, T G Armitage
Postgraduate Medical Journal|December 1, 1987
Immediate versus deferred treatment for early prostatic cancerP H Smith, T G Armitage
Postgraduate Medical Journal|January 1, 1983
Primary peritonitis in children and adultsT G Armitage, R C Williamson
Progress in Clinical and Biological Research|January 1, 1990
The biochemical monitoring of prostate cancer. Yorkshire Regional Urological Cancer Research GroupE H Cooper, T G Armitage
Progress in Clinical and Biological Research|January 1, 1990
Deferred treatment in localized prostatic cancerP H Smith, T G Armitage, E H Cooper
British Journal of Urology|December 1, 1988
The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancerT G Armitage, E H Cooper, D W Newling, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
Cancer|September 1, 1990
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancerE H Cooper, T G Armitage, M R Robinson, et al.
Pageof 1